Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Meredith Renfroe"'
Autor:
Christina Wu, Zhengjia Chen, Ganji Purnachandra Nagaraju, Chao Zhang, Walid L. Shaib, Edith Brutcher, Olatunji B. Alese, Meredith Renfroe, Hyun Soo Kim, Bassel F. El-Rayes
Publikováno v:
Cancer. 124:1992-2000
Background Neuroendocrine tumors (NETs) metastasize to the liver. Everolimus and selective internal radioembolization (SIRT) are approved treatments. Pasireotide is a somatostatin analogue with an affinity for somatostatin receptors 1, 2, 3, and 5. E
Autor:
Hyun S, Kim, Walid L, Shaib, Chao, Zhang, Ganji Purnachandra, Nagaraju, Christina, Wu, Olatunji B, Alese, Zhengjia, Chen, Edith, Brutcher, Meredith, Renfroe, Bassel F, El-Rayes
Publikováno v:
Cancer. 124(9)
Neuroendocrine tumors (NETs) metastasize to the liver. Everolimus and selective internal radioembolization (SIRT) are approved treatments. Pasireotide is a somatostatin analogue with an affinity for somatostatin receptors 1, 2, 3, and 5. Everolimus a
Autor:
Bradley C. Carthon, Zhengjia Chen, John S. Kauh, Gabriel Sica, Bassel F. El-Rayes, Wayne Harris, Meredith Renfroe, Suresh S. Ramalingam, R. Donald Harvey, Fadlo R. Khuri, Colleen Lewis, Rijalda Deović, Taofeek K. Owonikoko
Publikováno v:
Cancer Research. 75:CT303-CT303
Background: Preclinical work showed improved anticancer efficacy with the combination of an mTOR and a PI3K inhibitor over either agent alone. We conducted a phase I study to determine the recommended phase II dose (RP2D) of the combination of everol